Get App Open
In App
Open App
you are here:

JB Chemicals and Pharmaceuticals Ltd.

BSE: 506943 | NSE: JBCHEPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE572A01028 | SECTOR: Pharmaceuticals

BSE Live

Nov 25, 16:01
2042.00 -27.90 (-1.35%)
Volume
AVERAGE VOLUME
5-Day
6,638
10-Day
6,042
30-Day
4,665
2,922
  • Prev. Close

    2069.90

  • Open Price

    2072.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Nov 25, 15:58
2057.55 -12.30 (-0.59%)
Volume
AVERAGE VOLUME
5-Day
77,778
10-Day
94,932
30-Day
69,139
16,683
  • Prev. Close

    2069.85

  • Open Price

    2078.95

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    2057.55 (5)

Financials

2021 2020 2019 2018 2017
Balance Sheet of JB Chemicals and Pharmaceuticals (in Rs. Cr.) Mar 22 Mar 21 Mar 20 Mar 19 Mar 18  
  12 mths 12 mths 12 mths 12 mths 12 mths  
EQUITIES AND LIABILITIES  
SHAREHOLDER'S FUNDS  
Equity Share Capital 15.46 15.46 15.46 16.05 16.71  
Total Share Capital 15.46 15.46 15.46 16.05 16.71  
Reserves and Surplus 2,025.56 1,791.00 1,429.83 1,468.52 1,436.67  
Total Reserves and Surplus 2,025.56 1,791.00 1,429.83 1,468.52 1,436.67  
Total Shareholders Funds 2,103.67 1,806.46 1,445.29 1,484.56 1,453.39  
NON-CURRENT LIABILITIES  
Long Term Borrowings 0.00 0.00 0.00 0.00 0.00  
Deferred Tax Liabilities [Net] 51.92 63.77 58.85 71.15 49.70  
Other Long Term Liabilities 21.92 10.07 7.06 2.20 3.60  
Long Term Provisions 13.22 12.57 7.39 5.73 9.67  
Total Non-Current Liabilities 87.06 86.41 73.29 79.08 62.98  
CURRENT LIABILITIES  
Short Term Borrowings 26.32 26.43 32.04 25.80 28.48  
Trade Payables 196.24 164.02 111.35 76.71 100.22  
Other Current Liabilities 83.50 92.49 144.31 124.62 112.68  
Short Term Provisions 41.29 24.62 4.73 1.34 8.91  
Total Current Liabilities 347.34 307.56 292.43 228.47 250.29  
Total Capital And Liabilities 2,538.07 2,200.43 1,811.01 1,792.12 1,766.66  
ASSETS  
NON-CURRENT ASSETS  
Tangible Assets 548.54 542.27 565.33 542.54 559.94  
Intangible Assets 655.13 22.33 17.87 9.57 9.97  
Capital Work-In-Progress 13.91 25.57 16.17 15.09 17.40  
Other Assets 0.00 0.00 0.00 0.00 0.00  
Fixed Assets 1,222.34 590.17 599.37 567.20 587.31  
Non-Current Investments 145.69 145.88 202.42 228.84 182.92  
Deferred Tax Assets [Net] 0.00 0.00 0.00 0.00 0.00  
Long Term Loans And Advances 0.74 5.19 0.28 3.59 3.33  
Other Non-Current Assets 16.98 1.25 3.67 5.94 7.70  
Total Non-Current Assets 1,385.75 742.49 805.74 805.57 781.26  
CURRENT ASSETS  
Current Investments 0.00 664.97 333.81 360.65 383.77  
Inventories 349.78 278.91 232.04 208.10 175.81  
Trade Receivables 518.05 374.11 344.24 300.92 300.54  
Cash And Cash Equivalents 39.67 26.43 11.56 20.77 14.95  
Short Term Loans And Advances 0.75 1.65 4.02 0.71 0.21  
OtherCurrentAssets 244.06 111.87 79.60 95.39 110.11  
Total Current Assets 1,152.31 1,457.94 1,005.27 986.55 985.39  
Total Assets 2,538.07 2,200.43 1,811.01 1,792.12 1,766.66  
OTHER ADDITIONAL INFORMATION  
CONTINGENT LIABILITIES, COMMITMENTS  
Contingent Liabilities 68.13 117.00 121.66 86.45 173.76  
CIF VALUE OF IMPORTS  
Raw Materials 0.00 0.00 0.00 0.00 0.00  
Stores, Spares And Loose Tools 0.00 0.00 0.00 0.00 0.00  
Trade/Other Goods 0.00 0.00 0.00 0.00 0.00  
Capital Goods 0.00 0.00 0.00 0.00 0.00  
EXPENDITURE IN FOREIGN EXCHANGE  
Expenditure In Foreign Currency 214.26 179.21 215.30 192.31 616.39  
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS  
Dividend Remittance In Foreign Currency -- -- -- -- --  
EARNINGS IN FOREIGN EXCHANGE  
FOB Value Of Goods -- -- -- -- --  
Other Earnings 894.33 908.22 781.45 792.00 --  
BONUS DETAILS  
Bonus Equity Share Capital 8.46 8.46 8.46 8.78 9.14  
NON-CURRENT INVESTMENTS  
Non-Current Investments Quoted Market Value -- -- 56.57 83.84 39.86  
Non-Current Investments Unquoted Book Value 145.69 145.88 145.85 145.00 143.07  
CURRENT INVESTMENTS  
Current Investments Quoted Market Value -- 664.97 333.81 360.65 383.77  
Current Investments Unquoted Book Value -- -- -- -- --  
Source : Dion Global Solutions Limited